Literature DB >> 7772436

Cardiovascular responses to graded doses of three catecholamines during lactic and hydrochloric acidosis in dogs.

Y G Huang1, K C Wong, W H Yip, S W McJames, N L Pace.   

Abstract

We have studied the cardiovascular effects of incremental doses of three catecholamines in dogs subjected to lactic (LAC) and hydrochloric (HCl) acidosis. Fifty-four dogs were allocated randomly to one of three groups: control, LAC and HCl acidosis (n = 18 each group). In the acidotic models, 2 mol litre-1 of lactic acid (4 ml kg-1 h-1) or 2 mol litre-1 of HCl (1 ml kg-1 h-1) was infused i.v. until arterial pH was reduced to 7.00 +/- 0.1. Within each group, six dogs received one of three different drugs in logarithmically incremental doses: adrenaline 0.1, 0.2, 0.4, 0.8, 1.6, 3.2 micrograms kg-1 min-1, noradrenaline 0.1, 0.2, 0.4, 0.8, 1.6, 3.2 micrograms kg-1 min-1 and dobutamine 5, 10, 20, 40, 80, 160 micrograms kg-1 min-1. Cardiovascular variables were monitored, with periodic measurements of plasma electrolyte and lactate concentrations. The pH reduction induced by HCl or lactic acid was associated with a statistically significant increase in mean pulmonary arterial pressure (MPAP), prominent especially in the LAC group where MPAP increased from mean 18 (SD 5) to 27 (6) mm Hg. In the acidotic models, the reduction in myocardial responsiveness to adrenaline or noradrenaline was more prominent than that for the control for corresponding doses of drugs. In the LAC group mean cardiac index decreased significantly from 5.2 (1.8) to 2.2 (0.7) litre min-1 m-2 after infusion of adrenaline 3.2 micrograms kg-1 min-1 and decreased from 5.1 (1.1 to 2.4 (0.9) litre min-1 m-2 after infusion of noradrenaline 3.2 micrograms kg-1 min-1.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7772436     DOI: 10.1093/bja/74.5.583

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  7 in total

1.  [Vasopressin].

Authors:  W Schummer; C Schummer; J Fuchs
Journal:  Anaesthesist       Date:  2005-07       Impact factor: 1.041

Review 2.  Treatment options for lactic acidosis and metabolic crisis in children with mitochondrial disease.

Authors:  Katharina Danhauser; Jan A M Smeitink; Peter Freisinger; Wolfgang Sperl; Hemmen Sabir; Berit Hadzik; Ertan Mayatepek; Eva Morava; Felix Distelmaier
Journal:  J Inherit Metab Dis       Date:  2015-02-17       Impact factor: 4.982

3.  Early acid-base and blood pressure effects of continuous renal replacement therapy intensity in patients with metabolic acidosis.

Authors:  Rinaldo Bellomo; Miklos Lipcsey; Paolo Calzavacca; Michael Haase; Anjia Haase-Fielitz; Elisa Licari; Augustine Tee; Louise Cole; Alan Cass; Simon Finfer; Martin Gallagher; Joanne Lee; Serigne Lo; Colin McArthur; Shay McGuinness; John Myburgh; Carlos Scheinkestel
Journal:  Intensive Care Med       Date:  2013-01-11       Impact factor: 17.440

Review 4.  Treatment of acute metabolic acidosis: a pathophysiologic approach.

Authors:  Jeffrey A Kraut; Nicolaos E Madias
Journal:  Nat Rev Nephrol       Date:  2012-09-04       Impact factor: 28.314

5.  Treatment of Acidified Blood Using Reduced Osmolarity Mixed-Base Solutions.

Authors:  Thomas G Mason; Jeffrey A Kraut
Journal:  Front Physiol       Date:  2016-12-26       Impact factor: 4.566

6.  Acute but not chronic metabolic acidosis potentiates the acetylcholine-induced reduction in blood pressure: an endothelium-dependent effect.

Authors:  A C Celotto; L G Ferreira; V K Capellini; A A S Albuquerque; A J Rodrigues; P R B Evora
Journal:  Braz J Med Biol Res       Date:  2015-12-04       Impact factor: 2.590

Review 7.  Perioperative Management of Lactic Acidosis in End-Stage Liver Disease Patient.

Authors:  Alexander A Vitin; Leonard Azamfirei; Dana Tomescu; John D Lang
Journal:  J Crit Care Med (Targu Mures)       Date:  2017-05-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.